Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer

• John Nemunaitis,
• Laura Stanbery,
• Adam Walter,
• Adam Walter,
• Rodney Rocconi,
• Philip Stephens,
• Philip Stephens

Affiliations

John Nemunaitis

Gradalis, Inc, Dallas, TX, United States

Laura Stanbery

Gradalis, Inc, Dallas, TX, United States

Adam Walter

Gradalis, Inc, Dallas, TX, United States

Adam Walter

ProMedica, Toledo, OH, United States

Rodney Rocconi

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Mobile, AL, United States

Philip Stephens

Gradalis, Inc, Dallas, TX, United States

Philip Stephens

Naveris, Waltham, MA, United States